Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - CAPITAL EXPENDITURES
Capital Expenditures RARE - Ultragenyx Pharmaceutical Inc.
-46.8 M
LAST VALUE
20.01%
2 YEAR CAGR
-62.91%
5 YEAR CAGR
-60.71%
10 YEAR CAGR